Subscribe
Subscribe
泰格医药
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Tigermed, founded in December, 2014 and headquartered in Hangzhou, is a contract research organization (CRO) focused on providing professional services for the entire process of clinical trials for new drug research. The founder is Ye Xiaoping. Listed on the SZSE on August 17, 2012, the company's major shareholders are Ye Xiaoping, Hong Kong Securities Clearing Co., Ltd and Cao Xiaochun. Rivals that have direct and indirect competition with Tigermed include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Tigermed, founded in December, 2014 and headquartered in Hangzhou, is a contract research organization (CRO) focused on providing professional services for the entire process of clinical trials for new drug research. The founder is Ye Xiaoping. Listed on the SZSE on August 17, 2012, the company's major shareholders are Ye Xiaoping, Hong Kong Securities Clearing Co., Ltd and Cao Xiaochun. Rivals that have direct and indirect competition with Tigermed include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
GeneMind Biotech Closes Series B of CNY 140 Mn
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
China's NMPA Reduces Paperwork for Inland Producers to Make Exotic Medical Devices
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
JD Health’s New Move on Hong Kong IPO
Biotech IMAB’s In-Process New Drug Enters Clinical Trials
3D Printing Precision Medicine Industry Park Lands in Hunan
Antibody Developer Biocytogen Closes Series D+ at CNY 790 Mn
Edge Medical Robotics Closes Pre Series B at Over CNY 100 Mn
Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO
Genor Biopharma Passes the Hearing for Hong Kong IPO
WeChat’s Health Mini Program Has Access to Healthcare Reimbursement
Chunyu Doctor Closes Series E, Led-Invested by Sogou Technology
WeMed Secures CNY 100 Mn in Series C+ from GL Ventures
Singleron Biologics Receives USD 30 Mn in Series A for High-Throughput Sequencing
Surgical Robots Maker Jointech Closes Series B at Over CNY 100 Mn
EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.
We strive to make technology inclusive, accessible and transparent.
Join over 70,000 of your peers
Beijing
9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai
A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China
New York
800 Third Ave, 28F, New York, NY 10022, USA
Cooperation strategy
Products & prices
Customers & evaluation
